Assessment of the immune landscapes of advanced ovarian cancer in an optimized in vivo model

Background Ovarian cancer (OC) is typically diagnosed late, associated with high rates of metastasis and the onset of ascites during late stage disease. Understanding the tumor microenvironment and how it impacts the efficacy of current treatments, including immunotherapies, needs effective in vivo...

Ausführliche Beschreibung